by Richard Daverman, PhD
May 5, 2014 -- Harbin Gloria Pharma, a China injectable drugmaker, has joined Cumberland Pharma of Tennessee in Cumberland Emerging Technologies, a translational R&D effort. Both companies have made $1 million investments in CET, though Cumberland remains the majority owner. Gloria will have the right of first refusal on China rights to CET’s product candidates, which are discovered at Vanderbilt University in Nashville and other regional research centers. More details....
Stock Symbols: (SHE: 002437) (NSDQ: CPIX)
Help employers find you! Check out all the jobs and post your resume.
